東華大學圖書館 |

Language: English

Help

回圖書館首頁

手機版館藏查詢

Back

Switch To: Labeled | MARC Mode | ISBD

A Scalable, Point-of-Care, Microflui...

Rossi, Jason M.

Linked to FindBook

Google Book

Amazon

博客來

A Scalable, Point-of-Care, Microfluidic Approach for Assessing Thrombosis and Hemostasis.

Record Type:	Electronic resources : Monograph/item
Title/Author:	A Scalable, Point-of-Care, Microfluidic Approach for Assessing Thrombosis and Hemostasis./
Author:	Rossi, Jason M.
Published:	Ann Arbor : ProQuest Dissertations & Theses, : 2021,
Description:	156 p.
Notes:	Source: Dissertations Abstracts International, Volume: 82-12, Section: B.
Contained By:	Dissertations Abstracts International82-12B.
Subject:	Bioengineering. -
Online resource:	https://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=28419189
ISBN:	9798738649943

A Scalable, Point-of-Care, Microfluidic Approach for Assessing Thrombosis and Hemostasis.
Rossi, Jason M.

A Scalable, Point-of-Care, Microfluidic Approach for Assessing Thrombosis and Hemostasis. - Ann Arbor : ProQuest Dissertations & Theses, 2021 - 156 p.

Source: Dissertations Abstracts International, Volume: 82-12, Section: B.

Thesis (Ph.D.)--University of Pennsylvania, 2021.

This item must not be sold to any third party vendors.

Coagulation testing is an important diagnostic tool for the detection of excessive bleeding risk or obstructive clot formation (thrombosis), using blood samples from patients. Microfluidic flow devices have been well established to provide insights on the impacts of shear rate, drug action, and disease state on coagulation and platelet biology. The bulk of the microfluidic devices and assays used in the past have relied upon manual assembly using poly(dimethylsiloxane) (PDMS), a material and construction method not well suited to use in a clinical setting. This thesis describes the design and testing of a single-use, storage stable evolution of previous PDMS microfluidic designs, manufactured via injection molding and pressure-sensitive adhesive bonding. Using this device, we demonstrate the ability to make internally consistent and repeatable measurements of platelet and fibrin fluorescence intensity in clots forming under venous shear rate, using a bench-top LED microscope, and physiologically representative constant-pressure driven flow. We also demonstrate the ability to detect a strong, dose-dependent reduction in the fibrin fluorescence intensity signal in response to in vitro spiking of direct oral anticoagulants (DOACs). Further, we showed the ability to reverse this inhibition, through the addition of small quantities of drug reversal agents. In a separate study, the presence of DOACs in the blood of patients on the medications was clearly detected. Utilizing the previously obtained data from in vitro spiking, the relative response of DOAC patient blood with and without reversal agent was used to generate a quantitative prediction for the current concentration of drug in their system. The field of coagulation testing has lacked a definitive candidate for a fast, reliable means of accurately assessing patient anticoagulation status. Taken together, the ability to both identify the presence and predict the quantity of DOAC in a patient's blood using a single-use microfluidic chip approach, as described in this thesis, represents a potential promising new direction for coagulation testing at the bed-side.

ISBN: 9798738649943Subjects--Topical Terms:

657580
Bioengineering.
Subjects--Index Terms:

Flow simulations

A Scalable, Point-of-Care, Microfluidic Approach for Assessing Thrombosis and Hemostasis.
LDR:03416nmm a2200397 4500 001 2282940
005 20211022115804.5
008 220723s2021 ||||||||||||||||| ||eng d
020 $a 9798738649943
035 $a (MiAaPQ)AAI28419189
035 $a AAI28419189
040 $a MiAaPQ $c MiAaPQ
100 1 $a Rossi, Jason M. $3 3561827
245 1 0 $a A Scalable, Point-of-Care, Microfluidic Approach for Assessing Thrombosis and Hemostasis.
260 1 $a Ann Arbor : $b ProQuest Dissertations & Theses, $c 2021
300 $a 156 p.
500 $a Source: Dissertations Abstracts International, Volume: 82-12, Section: B.
500 $a Advisor: Diamond, Scott L.
502 $a Thesis (Ph.D.)--University of Pennsylvania, 2021.
506 $a This item must not be sold to any third party vendors.
506 $a This item must not be sold to any third party vendors.
520 $a Coagulation testing is an important diagnostic tool for the detection of excessive bleeding risk or obstructive clot formation (thrombosis), using blood samples from patients. Microfluidic flow devices have been well established to provide insights on the impacts of shear rate, drug action, and disease state on coagulation and platelet biology. The bulk of the microfluidic devices and assays used in the past have relied upon manual assembly using poly(dimethylsiloxane) (PDMS), a material and construction method not well suited to use in a clinical setting. This thesis describes the design and testing of a single-use, storage stable evolution of previous PDMS microfluidic designs, manufactured via injection molding and pressure-sensitive adhesive bonding. Using this device, we demonstrate the ability to make internally consistent and repeatable measurements of platelet and fibrin fluorescence intensity in clots forming under venous shear rate, using a bench-top LED microscope, and physiologically representative constant-pressure driven flow. We also demonstrate the ability to detect a strong, dose-dependent reduction in the fibrin fluorescence intensity signal in response to in vitro spiking of direct oral anticoagulants (DOACs). Further, we showed the ability to reverse this inhibition, through the addition of small quantities of drug reversal agents. In a separate study, the presence of DOACs in the blood of patients on the medications was clearly detected. Utilizing the previously obtained data from in vitro spiking, the relative response of DOAC patient blood with and without reversal agent was used to generate a quantitative prediction for the current concentration of drug in their system. The field of coagulation testing has lacked a definitive candidate for a fast, reliable means of accurately assessing patient anticoagulation status. Taken together, the ability to both identify the presence and predict the quantity of DOAC in a patient's blood using a single-use microfluidic chip approach, as described in this thesis, represents a potential promising new direction for coagulation testing at the bed-side.
590 $a School code: 0175.
650 4 $a Bioengineering. $3 657580
650 4 $a Biochemistry. $3 518028
650 4 $a Health care management. $3 2122906
653 $a Flow simulations
653 $a Haemodynamics
653 $a Immunofluorescence
653 $a Microfluidics
653 $a Proteins
653 $a Thrombosis
690 $a 0202
690 $a 0487
690 $a 0769
710 2 $a University of Pennsylvania. $b Chemical and Biomolecular Engineering. $3 2101616
773 0 $t Dissertations Abstracts International $g 82-12B.
790 $a 0175
791 $a Ph.D.
792 $a 2021
793 $a English
856 4 0 $u https://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=28419189